SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Amylin Pharmaceuticals, Inc. Release: SYMLIN® Use Helped Patients With Type 2 or Type 1 Diabetes Achieve More Time in Normal Glucose Range